Drug Discovery 2022: driving the next life science revolution

Dr Katrin Rittinger

Dr Katrin Rittinger
Dr Katrin Rittinger
Principal Group Leader
Francis Crick Institute
Delegate / Speaker

  Twitter

Presentations at Drug Discovery 2022: driving the next life science revolution

Profile of Dr Katrin Rittinger

Dr Katrin Rittinger is a Principal Group Leader at the Francis Crick Institute, London. After obtaining a degree in chemistry from the University of Heidelberg she completed her PhD at the Max Planck Institute for Medical Research in Heidelberg followed by a postdoc at the MRC-National Institute for Medical Research in London. She established her independent group in 2000 at the MRC-NIMR, which became part of the Francis Crick Institute in 2015. Her group is studying the mechanism and structural basis of intracellular signalling processes employing a broad range of biochemical, biophysical and structural approaches. Specifically, work in the group is focussed on protein ubiquitination as a key regulatory mechanism to drive cellular behaviour and the mechanism by which bacterial virulence factors interfere with host cell signalling to create a replicative niche. In parallel, she is collaborating with the Crick GSK LinkLabs to develop chemical probes that target the ubiquitin system.

Colleagues

Dr Barbara Domayne-Hayman
Entrepreneur-in-residence
Francis Crick Institute
Dr Scott Warchal
Bioinformatician
Francis Crick Institute

Email

Please login to send a Private Message

Hosted By

ELRIG

The European Laboratory Research & Innovation Group Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis

Get the App

Get this event information on your mobile by
going to the appstore or google play and search for 'elrig'